trending Market Intelligence /marketintelligence/en/news-insights/trending/pilyjaxddt_oxuwzfg3kiq2 content esgSubNav
In This List

RenovaCare appoints board chairman

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


RenovaCare appoints board chairman

RenovaCare Inc. appointed Harmel Rayat, a majority stockholder, as board chairman.

Rayat is an entrepreneur-investor, whose portfolio includes class A commercial properties in the U.S. and Canada. He has invested nearly $6 million in RenovaCare and its stem cell spray technologies.

New York-based RenovaCare is a development-stage company, which focuses on the acquisition, research, development and commercialization of autologous cellular therapies for use in medical and aesthetic applications.